Arvinas Agrees to License Prostate Cancer Treatment, Sell AR-V7 Program to Novartis
Arvinas Agrees to License Prostate Cancer Treatment, Sell AR-V7 Program to Novartis
Arvinas 同意許可前列腺癌治療，向諾華出售 AR-V7 計劃
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊